Terminology and classification of congenital vascular malformations

B B Lee1, J Laredo, T S Lee

  • 1Department of Surgery, Georgetown University, Washington DC, USA. bblee38@comcast.net

Phlebology
|February 16, 2008
PubMed

Insights

Congenital vascular malformations, specifically venous malformations (VMs), require updated classification. The Hamburg classification, based on embryology and pathology, offers a standardized approach for modern management of these venous system anomalies.

Area of Science:

  • Vascular biology and embryology
  • Medical diagnostics and classification systems

Background:

  • Venous malformation (VM) is a congenital vascular malformation (CVM) originating during embryogenesis.
  • Previous classification systems for VMs were often confusing and lacked clarity.
  • Advances in understanding CVMs necessitate a refined classification for effective management.

Purpose of the Study:

  • To introduce and explain the Hamburg classification for venous malformations.
  • To provide a standardized system for classifying VMs based on current scientific understanding.
  • To facilitate contemporary clinical management through a clearer classification framework.

Main Methods:

  • Reappraisal of older terminology and classification systems for VMs.
  • Development of a new classification based on anatomical, pathological, and embryological criteria.
  • Establishment of the Hamburg classification as a contemporary standard.

Main Results:

  • The Hamburg classification offers a standardized system for venous malformations.
  • This new system is based on robust anatomical, pathological, and embryological data.
  • It addresses the limitations of older, misleading terminology.

Conclusions:

  • The Hamburg classification provides a clear and scientifically grounded system for venous malformations.
  • This standardized approach is crucial for contemporary diagnosis and treatment.
  • It represents a significant advancement in the study and management of CVMs.

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...